Lincoln Pharmaceuticals Dividend
Dividend criteria checks 4/6
Lincoln Pharmaceuticals is a dividend paying company with a current yield of 0.25% that is well covered by earnings.
Key information
0.3%
Dividend yield
4%
Payout ratio
| Industry average yield | 0.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | ₹43.57 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Recent updates
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?
Oct 23Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year
Oct 05Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why
Sep 18Trade Alert: The MD & Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Mahendrabhai Patel, Has Just Spent ₹2.4m Buying 2.0% More Shares
Aug 31Earnings Working Against Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Share Price
Aug 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: LINCOLN's dividends per share have been stable in the past 10 years.
Growing Dividend: LINCOLN's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Lincoln Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LINCOLN) | 0.3% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast in 3 Years (LINCOLN) | n/a |
Notable Dividend: LINCOLN's dividend (0.25%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.26%).
High Dividend: LINCOLN's dividend (0.25%) is low compared to the top 25% of dividend payers in the Indian market (1.18%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (3.7%), LINCOLN's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (4.5%), LINCOLN's dividend payments are thoroughly covered by cash flows.